205 related articles for article (PubMed ID: 7605395)
1. Epidemic meningococcal meningitis in central Australia, 1987-1991.
Patel MS; Merianos A; Hanna JN; Vartto K; Tait P; Morey F; Jayathissa S
Med J Aust; 1993 Mar; 158(5):336-40. PubMed ID: 7605395
[TBL] [Abstract][Full Text] [Related]
2. Control of group C meningococcal disease in Australian aboriginal children by mass rifampicin chemoprophylaxis and vaccination.
Pearce MC; Sheridan JW; Jones DM; Lawrence GW; Murphy DM; Masutti B; McCosker C; Douglas V; George D; O'Keefe A
Lancet; 1995 Jul; 346(8966):20-3. PubMed ID: 7603139
[TBL] [Abstract][Full Text] [Related]
3. Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.
Woods CW; Armstrong G; Sackey SO; Tetteh C; Bugri S; Perkins BA; Rosenstein NE
Lancet; 2000 Jan; 355(9197):30-3. PubMed ID: 10615888
[TBL] [Abstract][Full Text] [Related]
4. Control of epidemic meningococcal meningitis by mass vaccination. I. Further epidemiological evaluation of groups A and C vaccines in northern Nigeria.
Mohammed I; Obineche EN; Onyemelukwe GC; Zaruba K
J Infect; 1984 Sep; 9(2):190-6. PubMed ID: 6438244
[TBL] [Abstract][Full Text] [Related]
5. Outbreak of group C meningococcal disease in Australian Aboriginal children.
Booy R
Lancet; 1995 Aug; 346(8974):572-3. PubMed ID: 7658793
[No Abstract] [Full Text] [Related]
6. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV
Sante; 1997; 7(6):384-90. PubMed ID: 9503496
[TBL] [Abstract][Full Text] [Related]
7. Control of epidemic meningococcal meningitis by mass vaccination.
Mohammed I; Zaruba K
Lancet; 1981 Jul; 2(8237):80-2. PubMed ID: 6113451
[No Abstract] [Full Text] [Related]
8. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.
Noronha CP; Struchiner CJ; Halloran ME
Int J Epidemiol; 1995 Oct; 24(5):1050-7. PubMed ID: 8557439
[TBL] [Abstract][Full Text] [Related]
9. Epidemic of meningococcal meningitis in Bamako, Mali: epidemiological features and analysis of vaccine efficacy.
Binkin N; Band J
Lancet; 1982 Aug; 2(8293):315-8. PubMed ID: 6124726
[TBL] [Abstract][Full Text] [Related]
10. Uncommon mixed outbreak of pneumococcal and meningococcal meningitis in Jirapa District, Upper West Region, Ghana, 2016.
Domo NR; Nuolabong C; Nyarko KM; Kenu E; Balagumyetime P; Konnyebal G; Noora CL; Ameme KD; Wurapa F; Afari E
Ghana Med J; 2017 Dec; 51(4):149-155. PubMed ID: 29622828
[TBL] [Abstract][Full Text] [Related]
11. Control of meningococcal infection in the African meningitis belt by selective vaccination.
Greenwood BM; Wali SS
Lancet; 1980 Apr; 1(8171):729-32. PubMed ID: 6103155
[TBL] [Abstract][Full Text] [Related]
12. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway.
Bjune G; Høiby EA; Grønnesby JK; Arnesen O; Fredriksen JH; Halstensen A; Holten E; Lindbak AK; Nøkleby H; Rosenqvist E
Lancet; 1991 Nov; 338(8775):1093-6. PubMed ID: 1682541
[TBL] [Abstract][Full Text] [Related]
13. Control of an outbreak of group C meningococcal meningitis with a polysaccharide vaccine.
Masterton RG; Youngs ER; Wardle JC; Croft KF; Jones DM
J Infect; 1988 Sep; 17(2):177-82. PubMed ID: 3141518
[TBL] [Abstract][Full Text] [Related]
14. Selective primary health care: strategies for control of disease in the developing world. XIII. Acute bacterial meningitis.
Greenwood BM
Rev Infect Dis; 1984; 6(3):374-89. PubMed ID: 6429812
[TBL] [Abstract][Full Text] [Related]
15. Pattern of the meningococcal meningitis outbreak in Northern Nigeria, 2009.
Bassey BE; Vaz RG; Gasasira AN; Braka F; Weldegriebriel G; Komakech W; Toritseju MS; Fatiregun AA; Okocha-Ejeko A
Int J Infect Dis; 2016 Feb; 43():62-67. PubMed ID: 26724773
[TBL] [Abstract][Full Text] [Related]
16. Current status of cerebrospinal meningitis and impact of the 2015 meningococcal C vaccination in Kebbi, Northwest Nigeria.
Ajibola O; Omoleke SA; Omisakin OA
Vaccine; 2018 Mar; 36(11):1423-1428. PubMed ID: 29426659
[TBL] [Abstract][Full Text] [Related]
17. [Application of SP-RIA in the antibody surveillance and serologic diagnosis of epidemic cerebrospinal meningitis].
Chen X
Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Dec; 14(6):366-70. PubMed ID: 8156584
[TBL] [Abstract][Full Text] [Related]
18. Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines.
Robbins JB; Schneerson R; Gotschlich EC; Mohammed I; Nasidi A; Chippaux JP; Bernardino L; Maiga MA
Bull World Health Organ; 2003; 81(10):745-50; discussion 751-5. PubMed ID: 14758435
[TBL] [Abstract][Full Text] [Related]
19. The 1990 meningococcal meningitis epidemic of Sarh (Chad): how useful was an earlier mass vaccination?
Lengeler C; Kessler W; Daugla D
Acta Trop; 1995 Jun; 59(3):211-22. PubMed ID: 7572427
[TBL] [Abstract][Full Text] [Related]
20. Effect of group-A meningococcal vaccine in army recruits in Finland.
Mäkelä PH; Käyhty H; Weckström P; Sivonen A; Renkonen OV
Lancet; 1975 Nov; 2(7941):883-6. PubMed ID: 53370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
